Cross-border converter
DB07 211000 → NACE Rev 2.1 equivalent (Malta)
Denmark's national activity classification (DB07) shares its 4-digit backbone with the EU NACE Rev 2.1 standard. We use that backbone to surface the equivalent NACE Rev 2.1 subclass(es) used in Malta.
Shared EU parent
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
211000
Fremstilling af farmaceutiske råvarer
Branchen omfatter fremstilling af farmaceutiske råvarer til brug i fx lægemidler. Branchen omfatter også forarbejdning af blod, fremstilling af kemisk rent sukker og forarbejdning af kirtler.
Malta's NACE Rev 2.1 does not split EU class 2110 into a national subclass, or its data isn't loaded yet.
About this conversion
DB07 is the activity classification used in Denmark. NACE Rev 2.1 is the equivalent system in Malta. Both are national implementations of EU NACE Rev 2.1, so any 5th-digit subclass in one system can be traced back to a shared 4-digit EU class — and from there, forward into the other country's subclasses.
This page is generated for the query "DB07 211000 to NACE Rev 2.1" and stays in sync with our monthly Market Intelligence sync.